| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
36,139 |
30,757 |
$2.27M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,332 |
6,635 |
$944K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
8,801 |
8,787 |
$723K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
7,931 |
7,419 |
$565K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,150 |
6,145 |
$513K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,590 |
2,586 |
$230K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
7,575 |
7,517 |
$115K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12,387 |
12,216 |
$106K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,295 |
1,293 |
$103K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
15,003 |
14,899 |
$98K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
7,813 |
7,799 |
$81K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,341 |
1,255 |
$49K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
427 |
423 |
$46K |
| 83655 |
|
2,606 |
2,601 |
$32K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,381 |
2,345 |
$32K |
| 81002 |
|
10,954 |
10,784 |
$30K |
| 99051 |
|
3,323 |
2,998 |
$25K |
| 99383 |
|
155 |
155 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,066 |
1,018 |
$12K |
| 99174 |
|
5,729 |
5,714 |
$11K |
| 90474 |
|
2,548 |
2,539 |
$11K |
| 96127 |
|
1,952 |
1,901 |
$9K |
| 99382 |
|
86 |
86 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
750 |
721 |
$6K |
| 0071A |
|
98 |
98 |
$4K |
| 99215 |
Prolong outpt/office vis |
27 |
27 |
$4K |
| 0072A |
|
75 |
75 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
12 |
12 |
$1K |
| 80061 |
Lipid panel |
106 |
103 |
$870.81 |
| 99441 |
|
98 |
87 |
$773.77 |
| 90651 |
|
599 |
599 |
$722.43 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
18 |
17 |
$681.58 |
| 0081A |
|
15 |
15 |
$578.35 |
| 0083A |
|
14 |
14 |
$542.05 |
| 0002A |
|
14 |
14 |
$531.79 |
| 0001A |
|
13 |
13 |
$493.94 |
| 96161 |
|
196 |
193 |
$247.91 |
| 90686 |
|
3,698 |
3,693 |
$110.21 |
| 90715 |
|
244 |
244 |
$38.28 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
2,540 |
2,535 |
$1.91 |
| 98966 |
|
339 |
317 |
$0.57 |
| G9007 |
Coordinated care fee, scheduled team conference |
194 |
194 |
$0.43 |
| 98967 |
|
69 |
59 |
$0.14 |
| 90707 |
|
2,162 |
2,153 |
$0.00 |
| 90633 |
|
2,300 |
2,290 |
$0.00 |
| 90700 |
|
1,213 |
1,209 |
$0.00 |
| 99072 |
|
328 |
283 |
$0.00 |
| 90734 |
|
495 |
495 |
$0.00 |
| 90670 |
|
4,123 |
4,098 |
$0.00 |
| 91300 |
|
48 |
43 |
$0.00 |
| 91308 |
|
60 |
53 |
$0.00 |
| 90716 |
|
2,153 |
2,145 |
$0.00 |
| 90696 |
|
822 |
818 |
$0.00 |
| 90680 |
|
2,733 |
2,711 |
$0.00 |
| 90647 |
|
3,228 |
3,207 |
$0.00 |
| 90723 |
|
3,171 |
3,149 |
$0.00 |
| 91307 |
|
176 |
155 |
$0.00 |
| 3048F |
|
32 |
31 |
$0.00 |
| 90620 |
|
26 |
26 |
$0.00 |
| 90688 |
|
30 |
30 |
$0.00 |